MDXG (MiMedx Group, Inc.) Stock Financials & Earnings | Market Cap Arena

MDXGMiMedx Group, Inc.

Mkt Cap$684M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$419M

Net Income (TTM)$49M

EPS (TTM)$0.32

Free Cash Flow (TTM)$69M

Gross Margin82.6%

Op. Margin15.3%

Net Margin11.6%

FCF Margin16.6%

P/S Ratio (TTM)1.6x

P/E Ratio (TTM)14.1x

YoY Rev Growth+20.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$72M	$59M	-$340K
Q2 23	$81M	$68M	$11M
Q3 23	$82M	$67M	$11M
Q4 23	$87M	$73M	$15M
Q1 24	$85M	$72M	$13M
Q2 24	$87M	$72M	$23M
Q3 24	$84M	$69M	$11M
Q4 24	$93M	$76M	$11M
Q1 25	$88M	$72M	$8M
Q2 25	$99M	$80M	$12M
Q3 25	$114M	$95M	$22M
Q4 25	$118M	$99M	$21M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	2.4x	—
Q2 23	2.3x	—
Q3 23	2.2x	157.8x
Q4 23	2.1x	11.7x
Q1 24	2.0x	9.4x
Q2 24	2.0x	7.7x
Q3 24	2.0x	7.7x
Q4 24	2.0x	16.1x
Q1 25	1.9x	17.0x
Q2 25	1.9x	21.3x
Q3 25	1.7x	16.8x
Q4 25	1.6x	14.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$4M	-$5M
Q2 23	$8M	$7M
Q3 23	$13M	$12M
Q4 23	$10M	$10M
Q1 24	$6M	-$166K
Q2 24	$22M	$21M
Q3 24	$20M	$14M
Q4 24	$19M	$19M
Q1 25	$5M	$5M
Q2 25	$14M	$14M
Q3 25	$29M	$25M
Q4 25	$25M	$25M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$633K
Q2 23	$299K
Q3 23	$628K
Q4 23	$427K
Q1 24	$6M
Q2 24	$419K
Q3 24	$5M
Q4 24	$0
Q1 25	$377K
Q2 25	$0
Q3 25	$4M
Q4 25	$377K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+21.7%	+5.6%
Q2 23	+21.5%	-8.0%
Q3 23	+20.7%	-5.6%
Q4 23	+16.7%	-2.7%
Q1 24	+18.2%	-0.7%
Q2 24	+7.3%	-9.5%
Q3 24	+2.9%	+3.3%
Q4 24	+7.0%	+14.7%
Q1 25	+4.1%	+11.8%
Q2 25	+13.1%	+35.3%
Q3 25	+35.3%	+25.6%
Q4 25	+27.1%	+18.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	5.4%
Q2 23	$4M	5.3%
Q3 23	$4M	5.4%
Q4 23	$0	0.0%
Q1 24	$4M	5.1%
Q2 24	$4M	4.7%
Q3 24	$4M	4.5%
Q4 24	$0	0.0%
Q1 25	$4M	4.8%
Q2 25	$5M	4.8%
Q3 25	$5M	4.3%
Q4 25	$7M	5.7%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$3M	—	—	$56M
Q2 23	$4M	—	—	$53M
Q3 23	$3M	—	—	$53M
Q4 23	$2M	—	—	$55M
Q1 24	$3M	—	—	$55M
Q2 24	$3M	—	—	$46M
Q3 24	$3M	—	—	$54M
Q4 24	$4M	—	—	$61M
Q1 25	$3M	—	—	$60M
Q2 25	$3M	$16M	$48M	—
Q3 25	$4M	—	—	$69M
Q4 25	$5M	—	—	$73M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$61M	$0	$61M
Q2 23	$69M	$0	$69M
Q3 23	$81M	$0	$81M
Q4 23	$82M	$0	$82M
Q1 24	$48M	$0	$48M
Q2 24	$69M	$0	$69M
Q3 24	$89M	$0	$89M
Q4 24	$104M	$0	$104M
Q1 25	$106M	$0	$106M
Q2 25	$119M	$0	$119M
Q3 25	$142M	$0	$142M
Q4 25	$166M	$0	$166M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	114M	+0.6%
Q2 23	116M	+1.3%
Q3 23	119M	+3.0%
Q4 23	148M	+24.1%
Q1 24	150M	+1.3%
Q2 24	149M	-0.8%
Q3 24	148M	-0.4%
Q4 24	149M	+0.5%
Q1 25	150M	+0.4%
Q2 25	149M	-0.2%
Q3 25	150M	+0.3%
Q4 25	150M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$306K	386
FY 15	$341K	550
FY 16	$355K	690
FY 17	$465K	690
FY 18	$477K	753
FY 19	$430K	696
FY 20	$338K	735
FY 21	$298K	811
FY 22	$309K	867
FY 23	$359K	895
FY 24	$417K	837
FY 25	$518K	808

MDXG (MiMedx Group, Inc.) Stock Financials & Earnings | Market Cap Arena